These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 18214821)

  • 21. Frailty syndrome diagnosed according to the Study of Osteoporotic Fractures criteria and mortality in older outpatients suffering from Alzheimer's disease: a one-year prospective cohort study.
    Bilotta C; Bergamaschini L; Nicolini P; Casè A; Pina G; Rossi SV; Vergani C
    Aging Ment Health; 2012; 16(3):273-80. PubMed ID: 21995585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in people with Alzheimer's disease (MAIN-AD).
    Ballard C; Thomas A; Gerry S; Yu LM; Aarsland D; Merritt C; Corbett A; Davison C; Sharma N; Khan Z; Creese B; Loughlin P; Bannister C; Burns A; Win SN; Walker Z;
    J Am Med Dir Assoc; 2015 Apr; 16(4):316-22. PubMed ID: 25523285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renin-angiotensin system blockers affect cognitive decline and serum adipocytokines in Alzheimer's disease.
    Furiya Y; Ryo M; Kawahara M; Kiriyama T; Morikawa M; Ueno S
    Alzheimers Dement; 2013 Sep; 9(5):512-8. PubMed ID: 23142434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solitary living in Alzheimer's disease over 3 years: association between cognitive and functional impairment and community-based services.
    Wattmo C; Londos E; Minthon L
    Clin Interv Aging; 2014; 9():1951-62. PubMed ID: 25484578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with increased caregivers' burden in several cognitive stages of Alzheimer's disease.
    Kamiya M; Sakurai T; Ogama N; Maki Y; Toba K
    Geriatr Gerontol Int; 2014 Apr; 14 Suppl 2():45-55. PubMed ID: 24650065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance-Based instrument to assess functional capacity in dementia: The Texas Functional Living Scale.
    Cullum CM; Saine K; Chan LD; Martin-Cook K; Gray KF; Weiner MF
    Neuropsychiatry Neuropsychol Behav Neurol; 2001; 14(2):103-8. PubMed ID: 11417663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of vascular lesions on cognition in Alzheimer's disease: a community-based study.
    Riekse RG; Leverenz JB; McCormick W; Bowen JD; Teri L; Nochlin D; Simpson K; Eugenio C; Larson EB; Tsuang D
    J Am Geriatr Soc; 2004 Sep; 52(9):1442-8. PubMed ID: 15341544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognosis of an abnormal one-leg balance in community-dwelling patients with Alzheimer's disease: a 2-year prospective study in 686 patients of the REAL.FR study.
    Sourdet S; van Kan GA; Soto ME; Houles M; Cantet C; Nourhashemi F; Vellas B; Pahor M; Rolland Y
    J Am Med Dir Assoc; 2012 May; 13(4):407.e1-6. PubMed ID: 22227074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
    Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C
    Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.
    Wilcock GK; Black SE; Hendrix SB; Zavitz KH; Swabb EA; Laughlin MA;
    Lancet Neurol; 2008 Jun; 7(6):483-93. PubMed ID: 18450517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of co-morbidity and frailty on the clinical manifestation of patients with Alzheimer's disease.
    Oosterveld SM; Kessels RP; Hamel R; Ramakers IH; Aalten P; Verhey FR; Sistermans N; Smits LL; Pijnenburg YA; van der Flier WM; Olde Rikkert MG; Melis RJ
    J Alzheimers Dis; 2014; 42(2):501-9. PubMed ID: 24898646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitively-Related Basic Activities of Daily Living Impairment Greatly Increases the Risk of Death in Alzheimers Disease.
    Liang FW; Chan W; Chen PJ; Zimmerman C; Waring S; Doody R
    PLoS One; 2016; 11(8):e0160671. PubMed ID: 27571265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Gingko biloba supplementation in Alzheimer's disease patients receiving cholinesterase inhibitors: data from the ICTUS study.
    Canevelli M; Adali N; Kelaiditi E; Cantet C; Ousset PJ; Cesari M;
    Phytomedicine; 2014 May; 21(6):888-92. PubMed ID: 24548724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depressive symptoms in Alzheimer's disease: natural course and temporal relation to function and cognitive status.
    Holtzer R; Scarmeas N; Wegesin DJ; Albert M; Brandt J; Dubois B; Hadjigeorgiou GM; Stern Y
    J Am Geriatr Soc; 2005 Dec; 53(12):2083-9. PubMed ID: 16398891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antipsychotics and cognitive decline in Alzheimer's disease: the LASER-Alzheimer's disease longitudinal study.
    Livingston G; Walker AE; Katona CL; Cooper C
    J Neurol Neurosurg Psychiatry; 2007 Jan; 78(1):25-9. PubMed ID: 16801350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mortality in Alzheimer's disease: a comparative prospective Korean study in the community and nursing homes.
    Suh GH; Kil Yeon B; Shah A; Lee JY
    Int J Geriatr Psychiatry; 2005 Jan; 20(1):26-34. PubMed ID: 15578675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Benefits of Memantine Treatment for Alzheimer's Disease in the Okayama Memantine Study II (OMS II).
    Matsuzono K; Yamashita T; Ohta Y; Hishikawa N; Koike M; Sato K; Kono S; Deguchi K; Nakano Y; Abe K
    J Alzheimers Dis; 2015; 47(2):487-93. PubMed ID: 26401570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of mortality in patients diagnosed with probable Alzheimer's disease.
    Bowen JD; Malter AD; Sheppard L; Kukull WA; McCormick WC; Teri L; Larson EB
    Neurology; 1996 Aug; 47(2):433-9. PubMed ID: 8757016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.
    Villemagne VL; Burnham S; Bourgeat P; Brown B; Ellis KA; Salvado O; Szoeke C; Macaulay SL; Martins R; Maruff P; Ames D; Rowe CC; Masters CL;
    Lancet Neurol; 2013 Apr; 12(4):357-67. PubMed ID: 23477989
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.